Tech Company Financing Transactions

Empire Genomics Funding Round

Private investors participated in a $250 thousand funding round for Empire Genomics. The round was announced by the company on 11/20/2014.

Transaction Overview

Company Name
Announced On
11/20/2014
Transaction Type
Debt
Amount
$250,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing - amended. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1000 Youngs Rd. 207
Williamsville, NY 14221
USA
Email Address
Overview
Our mission is to improve individual patient care through the integration of innovative molecular diagnostic technology.
Profile
Empire Genomics LinkedIn Company Profile
Social Media
Empire Genomics Company Twitter Account
Company News
Empire Genomics News
Facebook
Empire Genomics on Facebook
YouTube
Empire Genomics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Andrew Watson
  Andrew Watson LinkedIn Profile  Andrew Watson Twitter Account  Andrew Watson News  Andrew Watson on Facebook
Chief Scientific Officer
Norma Nowak
  Norma Nowak LinkedIn Profile  Norma Nowak Twitter Account  Norma Nowak News  Norma Nowak on Facebook
VP - Sales
Anthony Scarpello
  Anthony Scarpello LinkedIn Profile  Anthony Scarpello Twitter Account  Anthony Scarpello News  Anthony Scarpello on Facebook


 

 

Browse more venture capital transactions:

Prev: 11/20/2014: Sweetgreen venture capital transaction
Next: 11/20/2014: CipherCloud venture capital transaction

 

Share this article

 


About Database of VC Transactions

Our team works diligently to document every notable VC transaction. VC transactions reported here are derived from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary